asc protein Search Results


93
MedChemExpress human asc protein
Human Asc Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human asc protein/product/MedChemExpress
Average 93 stars, based on 1 article reviews
human asc protein - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
Alomone Labs antibody nav 1 8
Antibody Nav 1 8, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody nav 1 8/product/Alomone Labs
Average 94 stars, based on 1 article reviews
antibody nav 1 8 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Alomone Labs anti nav1 5
Anti Nav1 5, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti nav1 5/product/Alomone Labs
Average 90 stars, based on 1 article reviews
anti nav1 5 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Proteintech asc
Asc, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/asc/product/Proteintech
Average 93 stars, based on 1 article reviews
asc - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Alomone Labs anti nav1 5 rabbit primary antibody
Anti Nav1 5 Rabbit Primary Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti nav1 5 rabbit primary antibody/product/Alomone Labs
Average 95 stars, based on 1 article reviews
anti nav1 5 rabbit primary antibody - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
Alomone Labs polyclonal rabbit antibody
Polyclonal Rabbit Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit antibody/product/Alomone Labs
Average 93 stars, based on 1 article reviews
polyclonal rabbit antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Proteintech antibodies for ncoa6
Upregulation of <t>NCoA6</t> expression is correlated with PDAC progression. (A) NCoA6 expression is significantly increased in PDAC samples compared with normal tissues from TCGA and GTEx. (B) Representative images of IHC staining for NCoA6 in PDAC tumor tissues (T) and adjacent normal tissues (ANT). (C) IHC score of NCoA6 expression in PDAC and ANT ( n = 55, p < 0.001). (D) Representative images of IHC staining for NCoA6 in tissue microarrays. (E) Kaplan–Meier analysis of NCoA6 expression and overall survival ( p < 0.01) and disease‐free survival ( p < 0.05) of patients with PDAC from FUSCC. (F) The high NCoA6 expression group is associated with worse overall and disease‐free survival according to the Kaplan–Meier plotter database (hazard ratio [HR] = 1.44 and 3.15, respectively). (G) Time‐dependent ROC curve shows that NCoA6 expression in PDAC tissues from FUSCC is related to the 2‐year overall and disease‐free survival of patients (AUC = 0.822 and 0.707, respectively). (H) The ROC analysis from UCSC shows the moderate prognostic value of NCoA6 expression level in PDAC tissues (AUC = 0.811, p < 0.001).
Antibodies For Ncoa6, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies for ncoa6/product/Proteintech
Average 93 stars, based on 1 article reviews
antibodies for ncoa6 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Alomone Labs asc 002
Upregulation of <t>NCoA6</t> expression is correlated with PDAC progression. (A) NCoA6 expression is significantly increased in PDAC samples compared with normal tissues from TCGA and GTEx. (B) Representative images of IHC staining for NCoA6 in PDAC tumor tissues (T) and adjacent normal tissues (ANT). (C) IHC score of NCoA6 expression in PDAC and ANT ( n = 55, p < 0.001). (D) Representative images of IHC staining for NCoA6 in tissue microarrays. (E) Kaplan–Meier analysis of NCoA6 expression and overall survival ( p < 0.01) and disease‐free survival ( p < 0.05) of patients with PDAC from FUSCC. (F) The high NCoA6 expression group is associated with worse overall and disease‐free survival according to the Kaplan–Meier plotter database (hazard ratio [HR] = 1.44 and 3.15, respectively). (G) Time‐dependent ROC curve shows that NCoA6 expression in PDAC tissues from FUSCC is related to the 2‐year overall and disease‐free survival of patients (AUC = 0.822 and 0.707, respectively). (H) The ROC analysis from UCSC shows the moderate prognostic value of NCoA6 expression level in PDAC tissues (AUC = 0.811, p < 0.001).
Asc 002, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/asc 002/product/Alomone Labs
Average 93 stars, based on 1 article reviews
asc 002 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Alomone Labs rabbit anti na v 1 9
Upregulation of <t>NCoA6</t> expression is correlated with PDAC progression. (A) NCoA6 expression is significantly increased in PDAC samples compared with normal tissues from TCGA and GTEx. (B) Representative images of IHC staining for NCoA6 in PDAC tumor tissues (T) and adjacent normal tissues (ANT). (C) IHC score of NCoA6 expression in PDAC and ANT ( n = 55, p < 0.001). (D) Representative images of IHC staining for NCoA6 in tissue microarrays. (E) Kaplan–Meier analysis of NCoA6 expression and overall survival ( p < 0.01) and disease‐free survival ( p < 0.05) of patients with PDAC from FUSCC. (F) The high NCoA6 expression group is associated with worse overall and disease‐free survival according to the Kaplan–Meier plotter database (hazard ratio [HR] = 1.44 and 3.15, respectively). (G) Time‐dependent ROC curve shows that NCoA6 expression in PDAC tissues from FUSCC is related to the 2‐year overall and disease‐free survival of patients (AUC = 0.822 and 0.707, respectively). (H) The ROC analysis from UCSC shows the moderate prognostic value of NCoA6 expression level in PDAC tissues (AUC = 0.811, p < 0.001).
Rabbit Anti Na V 1 9, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti na v 1 9/product/Alomone Labs
Average 93 stars, based on 1 article reviews
rabbit anti na v 1 9 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Alomone Labs rabbit
Upregulation of <t>NCoA6</t> expression is correlated with PDAC progression. (A) NCoA6 expression is significantly increased in PDAC samples compared with normal tissues from TCGA and GTEx. (B) Representative images of IHC staining for NCoA6 in PDAC tumor tissues (T) and adjacent normal tissues (ANT). (C) IHC score of NCoA6 expression in PDAC and ANT ( n = 55, p < 0.001). (D) Representative images of IHC staining for NCoA6 in tissue microarrays. (E) Kaplan–Meier analysis of NCoA6 expression and overall survival ( p < 0.01) and disease‐free survival ( p < 0.05) of patients with PDAC from FUSCC. (F) The high NCoA6 expression group is associated with worse overall and disease‐free survival according to the Kaplan–Meier plotter database (hazard ratio [HR] = 1.44 and 3.15, respectively). (G) Time‐dependent ROC curve shows that NCoA6 expression in PDAC tissues from FUSCC is related to the 2‐year overall and disease‐free survival of patients (AUC = 0.822 and 0.707, respectively). (H) The ROC analysis from UCSC shows the moderate prognostic value of NCoA6 expression level in PDAC tissues (AUC = 0.811, p < 0.001).
Rabbit, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit/product/Alomone Labs
Average 93 stars, based on 1 article reviews
rabbit - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Alomone Labs rabbit anti nalcn
Upregulation of <t>NCoA6</t> expression is correlated with PDAC progression. (A) NCoA6 expression is significantly increased in PDAC samples compared with normal tissues from TCGA and GTEx. (B) Representative images of IHC staining for NCoA6 in PDAC tumor tissues (T) and adjacent normal tissues (ANT). (C) IHC score of NCoA6 expression in PDAC and ANT ( n = 55, p < 0.001). (D) Representative images of IHC staining for NCoA6 in tissue microarrays. (E) Kaplan–Meier analysis of NCoA6 expression and overall survival ( p < 0.01) and disease‐free survival ( p < 0.05) of patients with PDAC from FUSCC. (F) The high NCoA6 expression group is associated with worse overall and disease‐free survival according to the Kaplan–Meier plotter database (hazard ratio [HR] = 1.44 and 3.15, respectively). (G) Time‐dependent ROC curve shows that NCoA6 expression in PDAC tissues from FUSCC is related to the 2‐year overall and disease‐free survival of patients (AUC = 0.822 and 0.707, respectively). (H) The ROC analysis from UCSC shows the moderate prognostic value of NCoA6 expression level in PDAC tissues (AUC = 0.811, p < 0.001).
Rabbit Anti Nalcn, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti nalcn/product/Alomone Labs
Average 93 stars, based on 1 article reviews
rabbit anti nalcn - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Alomone Labs rabbit anti nav1 5 antibody
Upregulation of <t>NCoA6</t> expression is correlated with PDAC progression. (A) NCoA6 expression is significantly increased in PDAC samples compared with normal tissues from TCGA and GTEx. (B) Representative images of IHC staining for NCoA6 in PDAC tumor tissues (T) and adjacent normal tissues (ANT). (C) IHC score of NCoA6 expression in PDAC and ANT ( n = 55, p < 0.001). (D) Representative images of IHC staining for NCoA6 in tissue microarrays. (E) Kaplan–Meier analysis of NCoA6 expression and overall survival ( p < 0.01) and disease‐free survival ( p < 0.05) of patients with PDAC from FUSCC. (F) The high NCoA6 expression group is associated with worse overall and disease‐free survival according to the Kaplan–Meier plotter database (hazard ratio [HR] = 1.44 and 3.15, respectively). (G) Time‐dependent ROC curve shows that NCoA6 expression in PDAC tissues from FUSCC is related to the 2‐year overall and disease‐free survival of patients (AUC = 0.822 and 0.707, respectively). (H) The ROC analysis from UCSC shows the moderate prognostic value of NCoA6 expression level in PDAC tissues (AUC = 0.811, p < 0.001).
Rabbit Anti Nav1 5 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti nav1 5 antibody/product/Alomone Labs
Average 95 stars, based on 1 article reviews
rabbit anti nav1 5 antibody - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Upregulation of NCoA6 expression is correlated with PDAC progression. (A) NCoA6 expression is significantly increased in PDAC samples compared with normal tissues from TCGA and GTEx. (B) Representative images of IHC staining for NCoA6 in PDAC tumor tissues (T) and adjacent normal tissues (ANT). (C) IHC score of NCoA6 expression in PDAC and ANT ( n = 55, p < 0.001). (D) Representative images of IHC staining for NCoA6 in tissue microarrays. (E) Kaplan–Meier analysis of NCoA6 expression and overall survival ( p < 0.01) and disease‐free survival ( p < 0.05) of patients with PDAC from FUSCC. (F) The high NCoA6 expression group is associated with worse overall and disease‐free survival according to the Kaplan–Meier plotter database (hazard ratio [HR] = 1.44 and 3.15, respectively). (G) Time‐dependent ROC curve shows that NCoA6 expression in PDAC tissues from FUSCC is related to the 2‐year overall and disease‐free survival of patients (AUC = 0.822 and 0.707, respectively). (H) The ROC analysis from UCSC shows the moderate prognostic value of NCoA6 expression level in PDAC tissues (AUC = 0.811, p < 0.001).

Journal: Cancer Medicine

Article Title: Nuclear receptor coactivator 6 ( NCoA6 ) promotes cell proliferation, migration, and invasion in pancreatic cancer

doi: 10.1002/cam4.6427

Figure Lengend Snippet: Upregulation of NCoA6 expression is correlated with PDAC progression. (A) NCoA6 expression is significantly increased in PDAC samples compared with normal tissues from TCGA and GTEx. (B) Representative images of IHC staining for NCoA6 in PDAC tumor tissues (T) and adjacent normal tissues (ANT). (C) IHC score of NCoA6 expression in PDAC and ANT ( n = 55, p < 0.001). (D) Representative images of IHC staining for NCoA6 in tissue microarrays. (E) Kaplan–Meier analysis of NCoA6 expression and overall survival ( p < 0.01) and disease‐free survival ( p < 0.05) of patients with PDAC from FUSCC. (F) The high NCoA6 expression group is associated with worse overall and disease‐free survival according to the Kaplan–Meier plotter database (hazard ratio [HR] = 1.44 and 3.15, respectively). (G) Time‐dependent ROC curve shows that NCoA6 expression in PDAC tissues from FUSCC is related to the 2‐year overall and disease‐free survival of patients (AUC = 0.822 and 0.707, respectively). (H) The ROC analysis from UCSC shows the moderate prognostic value of NCoA6 expression level in PDAC tissues (AUC = 0.811, p < 0.001).

Article Snippet: Incubation with primary antibodies for NCoA6 (1:100, Proteintech) and FBW7 (1:200, Bethyl) was at 4°C overnight, followed by polymeric HRP‐labeled anti‐rabbit IgG (Boster, China) at 37°C for 30 min. Tissue slides were scored to assess protein expression.

Techniques: Expressing, Immunohistochemistry

Relationship between clinicopathological features and  NCoA6  expression in patients with pancreatic cancer.

Journal: Cancer Medicine

Article Title: Nuclear receptor coactivator 6 ( NCoA6 ) promotes cell proliferation, migration, and invasion in pancreatic cancer

doi: 10.1002/cam4.6427

Figure Lengend Snippet: Relationship between clinicopathological features and NCoA6 expression in patients with pancreatic cancer.

Article Snippet: Incubation with primary antibodies for NCoA6 (1:100, Proteintech) and FBW7 (1:200, Bethyl) was at 4°C overnight, followed by polymeric HRP‐labeled anti‐rabbit IgG (Boster, China) at 37°C for 30 min. Tissue slides were scored to assess protein expression.

Techniques: Expressing

Univariate and multivariate Cox regression of overall survival and disease‐free survival of patients with PDAC.

Journal: Cancer Medicine

Article Title: Nuclear receptor coactivator 6 ( NCoA6 ) promotes cell proliferation, migration, and invasion in pancreatic cancer

doi: 10.1002/cam4.6427

Figure Lengend Snippet: Univariate and multivariate Cox regression of overall survival and disease‐free survival of patients with PDAC.

Article Snippet: Incubation with primary antibodies for NCoA6 (1:100, Proteintech) and FBW7 (1:200, Bethyl) was at 4°C overnight, followed by polymeric HRP‐labeled anti‐rabbit IgG (Boster, China) at 37°C for 30 min. Tissue slides were scored to assess protein expression.

Techniques: Expressing

GO/KEGG analysis and GSEA of our RNA‐sequencing data. (A) Western blotting analysis of NCoA6 in PDAC lines. The H6C7 cell line was included as a negative control for the detection of endogenous NCoA6 expression, and β‐Actin was used as a control. (B) RT‐qPCR and (C) western blotting analysis of NCoA6 expression in NCoA6 PANC‐1 and SW1900 cells. The volcano plot (D) and heatmap (E) of gene alterations for NCoA6‐NC/sh PANC‐1 cells. (F) GSEA shows that SENESE_HDAC1_TARGETS_UP, the gene set from Human MSigDB Collections, is significantly enriched in the RNA‐sequencing dataset of NCoA6‐NC/sh PANC‐1 cells. (G) The main enriched GO/KEGG results of NCoA6‐NC/sh PANC‐1 cells.

Journal: Cancer Medicine

Article Title: Nuclear receptor coactivator 6 ( NCoA6 ) promotes cell proliferation, migration, and invasion in pancreatic cancer

doi: 10.1002/cam4.6427

Figure Lengend Snippet: GO/KEGG analysis and GSEA of our RNA‐sequencing data. (A) Western blotting analysis of NCoA6 in PDAC lines. The H6C7 cell line was included as a negative control for the detection of endogenous NCoA6 expression, and β‐Actin was used as a control. (B) RT‐qPCR and (C) western blotting analysis of NCoA6 expression in NCoA6 PANC‐1 and SW1900 cells. The volcano plot (D) and heatmap (E) of gene alterations for NCoA6‐NC/sh PANC‐1 cells. (F) GSEA shows that SENESE_HDAC1_TARGETS_UP, the gene set from Human MSigDB Collections, is significantly enriched in the RNA‐sequencing dataset of NCoA6‐NC/sh PANC‐1 cells. (G) The main enriched GO/KEGG results of NCoA6‐NC/sh PANC‐1 cells.

Article Snippet: Incubation with primary antibodies for NCoA6 (1:100, Proteintech) and FBW7 (1:200, Bethyl) was at 4°C overnight, followed by polymeric HRP‐labeled anti‐rabbit IgG (Boster, China) at 37°C for 30 min. Tissue slides were scored to assess protein expression.

Techniques: RNA Sequencing, Western Blot, Negative Control, Expressing, Control, Quantitative RT-PCR

NCoA6 knockdown decreases the proliferation, cell cycle, and apoptosis of pancreatic cancer cells. CCK‐8 assays (A, B) and colony formation assays (C, D) were used to test the proliferation of PDAC cells transfected with NCoA6 shRNAs. The representative images and statistical results of the cell cycle (E, F) and apoptosis (G, H) using flow cytometry. (I, J) Western blotting analysis of p21 and p27 expression in NCoA6‐silenced PANC‐1 and SW1990 cells. (K, L) Western blotting analysis of CDK4, CDK2, Cyclin D1, Cyclin E1, and Cyclin A2 expression in NCoA6‐silenced PANC‐1 and SW1990 cells.

Journal: Cancer Medicine

Article Title: Nuclear receptor coactivator 6 ( NCoA6 ) promotes cell proliferation, migration, and invasion in pancreatic cancer

doi: 10.1002/cam4.6427

Figure Lengend Snippet: NCoA6 knockdown decreases the proliferation, cell cycle, and apoptosis of pancreatic cancer cells. CCK‐8 assays (A, B) and colony formation assays (C, D) were used to test the proliferation of PDAC cells transfected with NCoA6 shRNAs. The representative images and statistical results of the cell cycle (E, F) and apoptosis (G, H) using flow cytometry. (I, J) Western blotting analysis of p21 and p27 expression in NCoA6‐silenced PANC‐1 and SW1990 cells. (K, L) Western blotting analysis of CDK4, CDK2, Cyclin D1, Cyclin E1, and Cyclin A2 expression in NCoA6‐silenced PANC‐1 and SW1990 cells.

Article Snippet: Incubation with primary antibodies for NCoA6 (1:100, Proteintech) and FBW7 (1:200, Bethyl) was at 4°C overnight, followed by polymeric HRP‐labeled anti‐rabbit IgG (Boster, China) at 37°C for 30 min. Tissue slides were scored to assess protein expression.

Techniques: Knockdown, CCK-8 Assay, Transfection, Flow Cytometry, Western Blot, Expressing

NCoA6 knockdown decreases the migration and invasion capacity of pancreatic cancer cells. Scratch assays (A, B) and transwell migration and invasion assays (C, D) were performed to assess the effect of NCoA6 silencing on pancreatic cancer cell lines. (E, F) Western blotting analysis of EMT protein expression in NCoA6‐silenced PANC‐1 and SW1990 cells.

Journal: Cancer Medicine

Article Title: Nuclear receptor coactivator 6 ( NCoA6 ) promotes cell proliferation, migration, and invasion in pancreatic cancer

doi: 10.1002/cam4.6427

Figure Lengend Snippet: NCoA6 knockdown decreases the migration and invasion capacity of pancreatic cancer cells. Scratch assays (A, B) and transwell migration and invasion assays (C, D) were performed to assess the effect of NCoA6 silencing on pancreatic cancer cell lines. (E, F) Western blotting analysis of EMT protein expression in NCoA6‐silenced PANC‐1 and SW1990 cells.

Article Snippet: Incubation with primary antibodies for NCoA6 (1:100, Proteintech) and FBW7 (1:200, Bethyl) was at 4°C overnight, followed by polymeric HRP‐labeled anti‐rabbit IgG (Boster, China) at 37°C for 30 min. Tissue slides were scored to assess protein expression.

Techniques: Knockdown, Migration, Western Blot, Expressing

Potential endogenous interactions of NCoA6, HDAC1, FBW7, and CDX2. (A, B) Co‐immunoprecipitation validated NCoA6 interaction with HDAC1 in PDAC cells. NCoA6 expression was negatively correlated with FBW7 and CDX2 expression. (C) Western blotting validated NCoA6 downregulation in FBW7 overexpressing PANC‐1 and SW1990 cells. (D, E) Correlation analysis of NCoA6 expression and FBW7 expression in PDAC tissues, as determined by the IHC score (*** p < 0.001). (F, G) Western blotting and RT‐qPCR validated CDX2 upregulation in NCoA6 knockdown PDAC cells. (H, I) Western blotting and RT‐qPCR validated CDX2 upregulation in HDAC1 knockdown PDAC cells. (J) AcH3, AcH4, and CDX2 were upregulated in HDAC inhibitor TSA‐treated PDAC cells (western blotting).

Journal: Cancer Medicine

Article Title: Nuclear receptor coactivator 6 ( NCoA6 ) promotes cell proliferation, migration, and invasion in pancreatic cancer

doi: 10.1002/cam4.6427

Figure Lengend Snippet: Potential endogenous interactions of NCoA6, HDAC1, FBW7, and CDX2. (A, B) Co‐immunoprecipitation validated NCoA6 interaction with HDAC1 in PDAC cells. NCoA6 expression was negatively correlated with FBW7 and CDX2 expression. (C) Western blotting validated NCoA6 downregulation in FBW7 overexpressing PANC‐1 and SW1990 cells. (D, E) Correlation analysis of NCoA6 expression and FBW7 expression in PDAC tissues, as determined by the IHC score (*** p < 0.001). (F, G) Western blotting and RT‐qPCR validated CDX2 upregulation in NCoA6 knockdown PDAC cells. (H, I) Western blotting and RT‐qPCR validated CDX2 upregulation in HDAC1 knockdown PDAC cells. (J) AcH3, AcH4, and CDX2 were upregulated in HDAC inhibitor TSA‐treated PDAC cells (western blotting).

Article Snippet: Incubation with primary antibodies for NCoA6 (1:100, Proteintech) and FBW7 (1:200, Bethyl) was at 4°C overnight, followed by polymeric HRP‐labeled anti‐rabbit IgG (Boster, China) at 37°C for 30 min. Tissue slides were scored to assess protein expression.

Techniques: Immunoprecipitation, Expressing, Western Blot, Quantitative RT-PCR, Knockdown

Schematic representation of the working model designed using FigDraw. NCoA6 plays an important role in promoting PDAC cell proliferation, migration, invasion and progression, and is potentially related to the expression of HDAC1, FBW7, and CDX2.

Journal: Cancer Medicine

Article Title: Nuclear receptor coactivator 6 ( NCoA6 ) promotes cell proliferation, migration, and invasion in pancreatic cancer

doi: 10.1002/cam4.6427

Figure Lengend Snippet: Schematic representation of the working model designed using FigDraw. NCoA6 plays an important role in promoting PDAC cell proliferation, migration, invasion and progression, and is potentially related to the expression of HDAC1, FBW7, and CDX2.

Article Snippet: Incubation with primary antibodies for NCoA6 (1:100, Proteintech) and FBW7 (1:200, Bethyl) was at 4°C overnight, followed by polymeric HRP‐labeled anti‐rabbit IgG (Boster, China) at 37°C for 30 min. Tissue slides were scored to assess protein expression.

Techniques: Migration, Expressing